The UCI retroactively disqualified him from the Tour de France yesterday (Wednesday), after cycling's governing body announced two dried blood samples provided by the Colombian on July 8 and 13 revealed the presence of banned painkiller tramadol.
The UCI clarified that because this is Quintana's first offence, though, he can still compete at the Vuelta and other upcoming races. However, the Colombian has decided to focus his efforts on defending himself at CAS, consequently withdrawing from the Grand Tour on the eve of the first stage in Utrecht.
"I announce that I will not participate in the Vuelta a España to assert my reasons before the Court of Arbitration for Sport (CAS)," Quintana stated. "I will return to the race calendar at the end of the season."
While the World Anti-Doping Association (WADA) doesn't include tramadol on its banned substance list, the UCI banned the substance in March 2019 due to the adverse side-effects the drug can cause.
Yesterday, the 32-year-old strongly denied using tramadol, which is a strong painkiller.
“Today I realised by surprise the news from the UCI of an infraction for the use of tramadol,” Quintana said. “I am totally unaware of the use of this substance, and I deny ever using it during my career.
“With my legal team we will exhaust every means to prepare my defence."
Already in the Netherlands preparing for the first three stages of the Vuelta, Quintana also added he would start the race despite the UCI's ruling. Ultimately, he has reversed that decision.
“I also want to confirm that I will be at the Vuelta a España, mounted on my bike to give the maximum for my team, my country, and my followers."
Arkéa-Samsic also acknowledged the UCI's ruling, but refused to comment further than a short, issued statement (opens in new tab).
"Arkéa-Samsic has taken note of the notification from the UCI received by Nairo Quintana informing him of the presence of Tramadol in two dried blood samples collected during the last Tour de France," the statement read.
"The UCI Medical Regulations provide for a ban on the use of Tramadol in competition for medical reasons from 1 March 2019.
"Furthermore, this breach of the UCI Medical Regulations does not result in a suspension for the rider.
"The Arkéa-Samsic team will make no further comment."
pic.twitter.com/477gU6zZ5LAugust 17, 2022
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Ryan is a staff writer for Cycling Weekly, having joined the team in September 2021. He first joined Future in December 2020, working across FourFourTwo, Golf Monthly, Rugby World and Advnture's websites, before making his way to cycling. After graduating from Cardiff University with a degree in Journalism and Communications, Ryan earned a NCTJ qualification to further develop as a writer.
Nairo Quintana to leave Arkéa-Samsic, six weeks after signing new contract
The Colombian is currently appealing his Tour de France disqualification
By Tom Davidson • Published
Alex Dowsett: Body Rocket's aero sensor system 'has the capacity to revolutionise cycling performance'
Body Rocket is yet another 'on bike' aero measurement system. We explain how it's different from the others
By Tom Epton • Published
What I learned from watching season three of Netflix's Movistar documentary ‘The Least Expected Day'
Enric Mas battles to reach the top and 'Superman' brings the drama in the latest instalment of the Spanish Eastenders
By Tom Thewlis • Published
A call from the King, media madness and special eclairs: Belgium goes crazy for Remco Evenepoel
The 22-year-old is the first Belgian to win a Grand Tour since 1978